Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia

1H MRS is evolving into an invaluable tool for brain tumor classification in humans based on pattern recognition analysis, but there is still room for improvement. Here we propose a new approach: to challenge tumor metabolism in vivo by a defined perturbation, and study the induced changes in MRS pattern. For this we recorded single voxel 1H MR spectra from mice bearing a stereotactically induced GL261 grade IV brain glioma during a period of induced acute hyperglycemia. A total of 29 C57BL/6 mice were used. Single voxel spectra were acquired at 7 T with point resolved spectroscopy and TE of 12, 30 and 136 ms. Tumors were induced by stereotactic injection of 105 GL261cells in 17 mice. Hyperglycemia (up to 338 ± 36 mg/dL glucose in the blood) was induced by intraperitoneal bolus injection. Maximal increases in glucose resonances of up to 2.4‐fold were recorded from tumors in vivo. Our observations are in agreement with extracellular accumulation of glucose, which may suggest that glucose transport and/or metabolism are working close to their maximum capacity in GL261 tumors. The significant and specific MRS pattern changes observed when comparing euglycemia and hyperglycemia may be of use for future pattern‐recognition studies of animal and human brain tumors by enhancing MRS‐based discrimination between tumor types and grades. Copyright © 2007 John Wiley & Sons, Ltd.

[1]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[2]  J. Frahm,et al.  Localized proton MRS of cerebral metabolite profiles in different mouse strains , 2003, Magnetic resonance in medicine.

[3]  M. Garwood,et al.  Localized detection of glioma glycolysis using edited 1H MRS , 1993, Magnetic resonance in medicine.

[4]  M. Décorps,et al.  High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. , 2001, Cancer research.

[5]  A R Tate,et al.  Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.

[6]  Glyn Johnson,et al.  Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology , 2003, Magnetic resonance in medicine.

[7]  B. Barrere,et al.  in vivo identification and monitoring of changes in rat brain glucose by two‐dimensional shift‐correlated 1h nmr spectroscopy , 1992, Magnetic resonance in medicine.

[8]  T Jones,et al.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas , 1983, Annals of neurology.

[9]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[10]  W. Paschen,et al.  Regional metabolism of experimental brain tumors , 2004, Acta Neuropathologica.

[11]  R. Amirnovin,et al.  Vascular Apoptosis and Involution in Gliomas Precede Neovascularization: A Novel Concept for Glioma Growth and Angiogenesis , 2000, Laboratory Investigation.

[12]  Michael Garwood,et al.  In vivo quantification of choline compounds in the breast with 1H MR spectroscopy , 2003, Magnetic resonance in medicine.

[13]  K Uğurbil,et al.  Observation of resolved glucose signals in 1H NMR spectra of the human brain at 4 Tesla , 1996, Magnetic resonance in medicine.

[14]  Robert J Gillies,et al.  High resolution pHe imaging of rat glioma using pH‐dependent relaxivity , 2006, Magnetic resonance in medicine.

[15]  L. Parada,et al.  The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.

[16]  Peter Andersen,et al.  Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T , 2004, Magnetic resonance in medicine.

[17]  F. Howe,et al.  Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.

[18]  R. Gruetter,et al.  Detection and assignment of the glucose signal in 1h nmr difference spectra of the human brain , 1992, Magnetic resonance in medicine.

[19]  Brian K. Rutt,et al.  Semi-automated segmentation and quantification of adipose tissue in calf and thigh by MRI: a preliminary study in patients with monogenic metabolic syndrome , 2006, BMC Medical Imaging.

[20]  P. Okunieff,et al.  Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. , 1989, Cancer research.

[21]  T. Mcknight,et al.  Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. , 2004, Seminars in oncology.

[22]  A. Bassols,et al.  Assignment of the 2.03 ppm resonance in in vivo 1H MRS of human brain tumour cystic fluid: contribution of macromolecules , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[23]  J. Frahm,et al.  Monitoring cerebral glucose in diabetics by proton MRS , 1991, The Lancet.

[24]  A. W. Simonetti,et al.  Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra , 2006, NMR in biomedicine.

[25]  R Gruetter,et al.  Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. , 1998, Cancer research.

[26]  Y. Mitsumoto,et al.  1H MRS identifies lactate rise in the striatum of MPTP‐treated C57BL/6 mice , 2006 .

[27]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .

[28]  R Gruetter,et al.  Extracellular–Intracellular Distribution of Glucose and Lactate in the Rat Brain Assessed Noninvasively by Diffusion-Weighted 1H Nuclear Magnetic Resonance Spectroscopy In Vivo , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  C. Arús,et al.  A possible cellular explanation for the NMR-visible mobile lipid (ML) changes in cultured C6 glioma cells with growth. , 2007, Biochimica et biophysica acta.

[30]  S. Nelson,et al.  DNA-microarray analysis of brain cancer: molecular classification for therapy , 2004, Nature Reviews Neuroscience.

[31]  M. Décorps,et al.  2D‐spatial/2D‐spectral spectroscopic imaging of intracerebral gliomas in rat brain , 2000, Magnetic resonance in medicine.

[32]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[33]  K Ugurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at 7 T , 2001, Magnetic resonance in medicine.

[34]  Armando Navarro-Vázquez,et al.  A Graphical Tool for the Prediction of Vicinal Proton-Proton 3JHH Coupling Constants , 2004, J. Chem. Inf. Model..

[35]  Terence W Nixon,et al.  High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo , 2006, Magnetic resonance in medicine.

[36]  Damien Galanaud,et al.  Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy , 2006, Magnetic resonance in medicine.

[37]  H. Merkle,et al.  Relationships Among Lactate Concentration, Blood Flow and Histopathologic Profiles in Rat C6 Glioma , 1996, NMR in biomedicine.

[38]  Franklyn A Howe,et al.  1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.

[39]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[40]  C. Arús,et al.  Taurine Detection by Proton Magnetic Resonance Spectroscopy in Medulloblastoma: Contribution to Noninvasive Differential Diagnosis with Cerebellar Astrocytoma , 2004, Neurosurgery.

[41]  H. Gendelman,et al.  Quantitative 1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease , 2005, The Journal of Neuroscience.

[42]  T. Ernst,et al.  Improved water suppression for localized in vivo 1H spectroscopy. , 1995, Journal of magnetic resonance. Series B.

[43]  S Cerdán,et al.  Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. , 2001, Cancer research.

[44]  J. Frahm,et al.  Cerebral glucose is detectable by localized proton NMR spectroscopy in normal rat brain in Vivo , 1991, Magnetic resonance in medicine.

[45]  Á. Chamorro,et al.  Why Does Acute Hyperglycemia Worsen the Outcome of Transient Focal Cerebral Ischemia?: Role of Corticosteroids, Inflammation, and Protein O-Glycosylation , 2006, Stroke.

[46]  J Hennig,et al.  RARE imaging: A fast imaging method for clinical MR , 1986, Magnetic resonance in medicine.

[47]  A. Seligman,et al.  Studies in Carcinogenesis: VIII. Experimental Production of Brain Tumors in Mice with Methylcholanthrene , 1939 .